Bahrain's National Health Regulatory Authority (NHRA) is working on new legislation to prevent the use of fake drugs in the kingdom, Gulf Daily News has reported. Around one third of medication sold in the kingdom could be fake, NHRA chief executive, Dr Baha Eldin Fathea, told the daily. Several leading drug companies have already contacted authorities in Bahrain saying they cannot be held responsible for any adverse effects caused by people consuming fake medication, Dr Fathea said. "Around 30% of medications anywhere in the world are considered spurious or counterfeit," he said. "The same figures stand true for Bahrain as well but the truth is that with the proper legislation and control, the situation in Bahrain can easily be far better."